AdaptVac ApS is a Danish APS based in Frederiksberg, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2017, the company has 8 employees and reported a gross profit of -DKK 3.2m in its latest annual filing.
Selskabet tegnes af den administrerende direktør og en direktør i
forening eller af 4 medlemmer af bestyrelsen i forening.
Company purpose
Virksomhedens formål er at udvikle produkter og teknologi indenfor området vacciner og immunterapi samt hermed efter ledelsens skøn beslægtet virksomhed og serviceydelser.
In its most recent annual report (2025), AdaptVac ApS reported a gross profit of -DKK 3.2m, a decrease of 138% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of DKK 7.1m.
